Navigation Links
Nektar Announces Restructuring to Complete Its Transition to a Therapeutics Drug Development Organization
Date:2/12/2008

ET. Information on the dial-in details and Webcast of the call will be posted on the Investor Relations section of the Nektar website, http://www.nektar.com.

About Nektar

Nektar Therapeutics is a biopharmaceutical company that develops and enables differentiated therapeutics with its industry-leading PEGylation and pulmonary drug development platforms. Nektar PEGylation and pulmonary technology, expertise, manufacturing capabilities have enabled ten approved products for partners, which include the world's leading pharmaceutical and biotechnology companies. Nektar also develops its own products by applying its PEGylation and pulmonary technology platforms to existing medicines with the objective to enhance performance, such as improving efficacy, safety and compliance.

This press release contains forward-looking statements regarding management's plans and expectations for Nektar's organizational development and impact on its business objectives and its proprietary and partner product candidates currently in clinical development. These forward-looking statements involve substantial risks and uncertainties, including but not limited to: (i) the company may not realize the anticipated benefits to its business from the organizational developments described in this press release, (ii) the risk of failure of any product candidate that is in clinical development and prior to regulatory approval, such as the NKTR-102, NKTR-118, and NKTR-061, remains high and can occur at any stage due to efficacy, safety or other factors, (iii) clinical trials for the company's proprietary product candidates such as NKTR-102, NKTR-118 and NKTR-061 are long, expensive and uncertain processes, (iv) the ability of the company to the to obtain regulatory approval of NKTR-102, NKTR-118 and NKTR-061 is difficult to predict at any stage of development, (v) the company's patent applications for its technology platforms and prop
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Nektar Appoints Hoyoung Huh, M.D., Ph.D., to Serve on the Companys Board of Directors
2. Nektar Therapeutics President and CEO Howard W. Robin to Present At JPMorgan 26th Annual Healthcare Conference
3. Nektar Therapeutics to Present at 2007 BMO Capital Markets Focus on Healthcare Conference
4. Nektar Therapeutics President and CEO Howard Robin to Present at 2007 BIO InvestorForum
5. Drs. John Patton of Nektar, Igor Gonda of Aradigm, Tomas Landh of Novo Nordisk, Chris Rhodes of Amylin to Speak at iiBIGs Plenary Panel in Vegas
6. Nektar Presents Positive Results from Phase 1 Clinical Trial of NKTR-118 (oral PEG-naloxol) at American College of Clinical Pharmacology Meeting
7. Nektar Therapeutics Appoints Lutz Lingnau as New Board Member
8. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
9. PAREXEL International Announces 2-For-1 Stock Split
10. Anesiva Announces Fourth Quarter and Year-End 2007 Financial Results and Provides 2008 Outlook
11. Elekta Announces First Volumetric Modulated Arc Therapy Cancer Treatment at Royal Marsden Hospital

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2009)...ka-dotted postage stamp that can sniff out poisono...s. , As reported in the Sept. 13 issue of the jo...team at the University of Illinois have developed ...xic industrial chemicals (TICs) that is simple, fa.... This sensor array could be useful in detecting ...
(Date:11/18/2009)... in data analysis combined with Bio-Rad,s Biot...urricula provide state-of-the-art solutions to bio... 18 Vernier Software & Technol... sensors, and software and Bio-Rad Laboratories, I...of life science research and clinical diagnostics ...
(Date:11/18/2009)... Reportlinker.com announces that a ...alogue. ,, Biotechnology Reagents - A Global ...er.com/p0164375/Biotechnology-Reagents---A-Global-...utm_medium=pr&utm_campaign=prnewswire ,, ...l compounds used in a range of biotech related are...
(Date:11/18/2009)... Nov. 18 Algenol Biofuels LLC, dev... the technology group The Linde Group have agree... order to identify the optimum management of carbo...ue algae and photobioreactor technology. This coop...lop cost-efficient technologies that capture, stor...
Breaking Biology Technology:Opto-electronic nose sniffs out toxic gases 2Opto-electronic nose sniffs out toxic gases 3Vernier and Bio-Rad to Offer Enhanced Solutions for Biotechnology Education 2Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 2Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 3Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 4Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 5Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 6Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 7Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 8Algenol Biofuels and The Linde Group Agree To Cooperate in CO2 and O2 Management For Biofuel Production From Algae 2Algenol Biofuels and The Linde Group Agree To Cooperate in CO2 and O2 Management For Biofuel Production From Algae 3
...BERKELEY, CA -- Make way for the real nanopod and ... researchers with the U.S. Department of Energys L...) and the University of California at Berkeley hav...single carbon nanotube, which makes it by several ..., A single carbon nanotube molecule serves simult...
... TALLAHASSEE, Fla. -- Engineers at Florida State U... have successfully tested a groundbreaking new mag...nanoscience and semiconductor research. , When th...perational in 2010, researchers will have the abil...not only down the bore, or center, of the magnet, ...
... DIEGO, Oct. 31 Senomyx, Inc. (Nasdaq:,SNMX), a l...logies to,discover and develop novel flavor ingred... announced today that its discovery and developmen... conclude on December 9,2007, which is one year ea...ement. The conclusion of this collaboration does n...
Other Biology Technology:Make way for the real nanopod 2Make way for the real nanopod 3Make way for the real nanopod 4Let there be light: new magnet design continues magnet lab's tradition of innovation 2Senomyx Announces Conclusion of Discovery and Development Collaboration With Kraft Foods Global, Inc. 2Senomyx Announces Conclusion of Discovery and Development Collaboration With Kraft Foods Global, Inc. 3
(Date:11/20/2009)...ax shives, and generated from Brassica carinata ,...gulf fields in spring, can be used to produce bioe...ried out by Spanish and Dutch researchers and publ...ergy Reviews . , "These studies evaluate, from an...oethanol from two, as yet unexploited sources of b...
(Date:11/19/2009)... end of the last ice age, North America,s vast ass...eatures as mammoths, mastodons, camels, horses, gr...tous slide to extinction. , And when their popul... large animals equaled or surpassed Africa,s wildl... novel ecosystem emerged as broadleaved trees once...
(Date:11/19/2009)...ulti-institutional effort co-led by three Cold Spr... today in publication of a landmark series of pape...nted detail the DNA sequence of maize ( Zea mays )...h American consumers, is one of the world,s most i... crop grown in the United States, representing $47...
Breaking Biology News(10 mins):Flax and yellow flowers can produce bioethanol 2After mastodons and mammoths, a transformed landscape 2After mastodons and mammoths, a transformed landscape 3Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 2Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 3Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 4Exercise helps patients with non alcoholic fatty liver disease 50560 1Exercise helps patients with non alcoholic fatty liver disease 50560 2Schwarzenegger Administration Sued for Allowing Health Insurance Companies to Deny Autism Care 50557 1Schwarzenegger Administration Sued for Allowing Health Insurance Companies to Deny Autism Care 50557 2Schwarzenegger Administration Sued for Allowing Health Insurance Companies to Deny Autism Care 50557 3Schwarzenegger Administration Sued for Allowing Health Insurance Companies to Deny Autism Care 50557 4Schwarzenegger Administration Sued for Allowing Health Insurance Companies to Deny Autism Care 50557 5Video 3A Axel Ullrich Named Winner of 2009 Dr Paul Janssen Award for Biomedical Research 12873 1Video 3A Axel Ullrich Named Winner of 2009 Dr Paul Janssen Award for Biomedical Research 12873 2Video 3A Axel Ullrich Named Winner of 2009 Dr Paul Janssen Award for Biomedical Research 12873 3Video 3A Axel Ullrich Named Winner of 2009 Dr Paul Janssen Award for Biomedical Research 12873 4Video 3A Axel Ullrich Named Winner of 2009 Dr Paul Janssen Award for Biomedical Research 12873 5
...at showcase applications ranging from early-stage ... University of Houston will be well represented at...al Society (ACS), March 13 to 17 in San Diego. , F... and educational organization and the largest scie...membership of more than 159,000 chemists and chemi...
...ible to invasion by alien plant species, the const...ntributing to the accelerating spread of exotic aq... June 2005 issue of BioScience. John A. Havel of S... Lee and M. Jake Vander Zanden of the University o...ysical and biological properties of reservoirs mak...
...that infectious misformed proteins cause mad cow d...earchers at the University of Texas Medical Branch...roof yet that the mysterious and devastating brain...halopathies" (TSEs) are transmitted by an infectio... not a virus. TSEs, which can afflict both human b...
Other Biology News:Disease diagnosis, biodefense among UH chemical research projects 2Disease diagnosis, biodefense among UH chemical research projects 3Reservoirs may accelerate the spread of invasive aquatic species, researchers say 2Strongest proof yet found for prion hypothesis 2
Rabbit Anti-Human ALPHA-2-ANTIPLASMIN Polyclonal Antibody, Unconjugated from AbD Serotec
...ermostable recombinant DNA polymerase, which exhib...er molecular biology applications. Red Taq contain...cation of reactions to which enzyme was added and ...dye has no effect on downstream processes. Red Taq...
RNA oligos ready-to-use from Thermo Scientific
iEMS Incubator/Shaker HT from Thermo Scientific
Biology Products: